Article
A Sensitive Peptide Nucleic Acid Probe Assay for Detection of BRAF V600 Mutations in Melanoma.
Cancer genomics & proteomics - 1 Jan 2000
Chen Tai-Long, Chang John Wen-Cheng, Hsieh Jia-Juan, Cheng Hsin-Yi, Chiou Chiuan-Chian
Abstract excerpt
Mutated v-Raf murine sarcoma viral oncogene homolog B (BRAF) is an important biomarker for the prediction of therapeutic efficacy of several anticancer drugs. The detection of BRAF mutation faces two challenges: Firstly, there are multiple types of mutations, and secondly, tumor samples usually contain various amounts of wild-type, normal tissues. Here, we describe a newly established method for sensitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
